Release Notes: Version 20200611
About this release
This release (version 20200611) provides the latest updates to the Canadian Clinical Drug Data Set in English and French and represents the Health Canada Drug Product Database changes from April and May 2020. A separate InfoScribe location for the French supporting documents, including the French Release Notes, can be found here.
There is no change to the Technical Specification or the Editorial Guidelines.
The Canadian Clinical Drug Data Set is available for browsing and download via the Infoway Terminology Gateway.
Supporting general information can be found on Infoway Canadian Clinical Drug Data Set InfoCentral page.
General Notes
The following files are available as full release files within this version:
- Manufactured Product,
- Non-proprietary Therapeutic Product,
- Therapeutic Moiety,
- Manufactured Product-Non-proprietary Therapeutic Product-Therapeutic Product Relationship, in English (MP-NTP-TM Relationship),
- Manufactured Product-Non-proprietary Therapeutic Product-Therapeutic Product Relationship, in French (Relation PM-PTC-FT),
- Special Groupings,
- Coded Attribute, and
- Device Non-proprietary Therapeutic Product.
The "Full" release contains one entry for every concept that has ever been released and new content added for that release. New content added for a specific release may at times include “Inactive” content.
NOTE: The “Delta" release which is intended to contain only those concepts that have been added or changed since the previous release will be considered for a future enhancement at a later date.
This release reflects additions and changes that have occurred in DPD since the last CCDD release.
Device NTP
There are four new Device NTP concepts with this release.
device_ntp_code | device_ntp_formal_name | device_ntp_fr_description | device_ntp_status |
|---|---|---|---|
| 600004 | valved holding chamber with infant mask | chambre de retenue valvée avec masque pour nourrisson | Active |
| 600005 | valved holding chamber with child mask | chambre de retenue valvée avec masque pour enfant | Active |
| 600006 | valved holding chamber with adult mask | chambre de retenue valvée avec masque pour adulte | Active |
| 600007 | valved holding chamber with mouthpiece | chambre de retenue valvée avec embout buccal | Active |
NTP
There are 3 new deprecated NTP concepts with this release. In the first concept, the ingredient name for the corresponding product changed in DPD. In the second concept, the dosage form for the corresponding product changed in DPD. In the third concept, the strength for the corresponding product was changed to presentation strength as per the Editorial Guidelines since the 50 mL presentation is a pharmacy bulk vial.
| 9001632 | chloroquine diphosphate 250 mg oral tablet | diphosphate de chloroquine 250 mg comprimé oral | Deprec | 9014264 | chloroquine phosphate 250 mg oral tablet | phosphate de chloroquine 250 mg comprimé oral |
9013783 | dextromethorphan hydrobromide 10 mg per 5 mL and guaifenesin 100 mg per 5 mL oral solution | bromhydrate de dextrométhorphane 10 mg par 5 mL et guaïfénésine 100 mg par 5 mL solution orale | Deprec | 9014268 | dextromethorphan hydrobromide 10 mg per 5 mL and guaifenesin 100 mg per 5 mL syrup | bromhydrate de dextrométhorphane 10 mg par 5 mL et guaïfénésine 100 mg par 5 mL sirop |
| 9000884 | fentanyl (fentanyl citrate) 2500 mcg per 50 mL solution for injection vial | fentanyl (citrate de fentanyl) 2500 mcg par 50 mL solution injectable fiole | Deprec | 9014297 | fentanyl (fentanyl citrate) 50 mcg per mL solution for injection 50 mL vial | fentanyl (citrate de fentanyl) 50 mcg par mL solution injectable 50 mL fiole |
ntp_code | ntp_formal_name | ntp_fr_description | Type of change | Replaced with ntp_code | Replaced with ntp_formal_name | Replaced with ntp_fr_description |
|---|
MP
Three MP formal name changes have occurred resulting from the deprecated NTPs.
| 00021261 | TEVA-CHLOROQUINE (chloroquine phosphate 250 mg oral tablet) TEVA CANADA LIMITED | TEVA-CHLOROQUINE (phosphate de chloroquine 250 mg comprimé oral) TEVA CANADA LIMITED | TEVA-CHLOROQUINE (chloroquine diphosphate 250 mg oral tablet) TEVA CANADA LIMITED | TEVA-CHLOROQUINE (diphosphate de chloroquine 250 mg comprimé oral) TEVA CANADA LIMITED |
| 02248568 | ROBITUSSIN SUGAR FREE COUGH CONTROL (dextromethorphan hydrobromide 10 mg per 5 mL and guaifenesin 100 mg per 5 mL syrup) GLAXOSMITHKLINE CONSUMER HEALTHCARE INC. | ROBITUSSIN SUGAR FREE COUGH CONTROL (bromhydrate de dextrométhorphane 10 mg par 5 mL et guaïfénésine 100 mg par 5 mL sirop) GLAXOSMITHKLINE CONSUMER HEALTHCARE INC. | ROBITUSSIN SUGAR FREE COUGH CONTROL (dextromethorphan hydrobromide 10 mg per 5 mL and guaifenesin 100 mg per 5 mL oral solution) PFIZER CONSUMER HEALTHCARE A DIVISION OF PFIZER CANADA ULC | ROBITUSSIN SUGAR FREE COUGH CONTROL (bromhydrate de dextrométhorphane 10 mg par 5 mL et guaïfénésine 100 mg par 5 mL solution orale) PFIZER CONSUMER HEALTHCARE A DIVISION OF PFIZER CANADA ULC |
| 77700451 | FENTANYL CITRATE INJECTION USP (fentanyl (fentanyl citrate) 50 mcg per mL solution for injection 50 mL vial) SANDOZ CANADA INCORPORATED | FENTANYL CITRATE INJECTION USP (fentanyl (citrate de fentanyl) 50 mcg par mL solution injectable 50 mL fiole) SANDOZ CANADA INCORPORATED | FENTANYL CITRATE INJECTION USP (fentanyl (fentanyl citrate) 2500 mcg per 50 mL solution for injection vial) SANDOZ CANADA INCORPORATED | FENTANYL CITRATE INJECTION USP (fentanyl (citrate de fentanyl) 2500 mcg par 50 mL solution injectable fiole) SANDOZ CANADA INCORPORATED |
mp_code June Release | mp_formal_name June Release | mp_fr_description June Release | mp_formal_name April Release | mp_fr_description April Release |
|---|
| mp_code | mp_formal_name | mp_fr_description | mp_status June | mp_status April |
|---|---|---|---|---|
| 02480379 | AUVI-Q (epinephrine 0.3 mg per 0.3 mL solution for injection syringe) KALEO INC | AUVI-Q (épinéphrine 0,3 mg par 0,3 mL solution injectable seringue) KALEO INC | Inactive | Active |
| 02480360 | AUVI-Q (epinephrine 0.15 mg per 0.15 mL solution for injection syringe) KALEO INC | AUVI-Q (épinéphrine 0,15 mg par 0,15 mL solution injectable seringue) KALEO INC | Inactive | Active |
Questions, Concerns, Changes
Questions and concerns and suggestions for future consideration are welcomed and should be sent by e-mail at [email protected]